YOUR BUSINESS AUTHORITY

Springfield, MO

Log in Subscribe

Merck to acquire cancer-treatment biotech firm

Posted online

Merck & Co. Inc. announced plans to purchase biopharmaceutical company Tilos Therapeutics.

The deal for the cancer-treatment biotechnology firm could be valued at up to $773 million.

The deal includes an up-front payment and milestone payouts.

Read more from MarketWatch.

Comments

No comments on this story |
Please log in to add your comment
Editors' Pick
Open for Business: Fortified Elder Law

Fortified Elder Law LLC moved; Weston Kissee, a 17-year employee with St. Louis-based financial services firm Edward Jones, relocated; and Monroe Coffee Co. changed ownership.

Most Read
Update cookies preferences